EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation

Macarena S Arrázola iD, Matías Lira iD, Felipe Véliz-Valverde iD, Gabriel Quiroz iD, Somya Iqbal iD, Samantha L Eaton, Douglas J Lamont iD, Hernán Huerta iD, Gonzalo Ureta iD, Sebastián Bernales, J César Cárdenas iD, Waldo Cerpa iD und 2 weitere

Aging Cell · 2023-05 · 22 (5)

DOI: 10.1111/acel.13814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 27.03.2023. Verfasst von Macarena S Arrázola und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile. Hauptthemen laut MEDLINE: Necroptosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Fondo Nacional de Desarrollo Científico y Tecnológico, Michael J. Fox Foundation for Parkinson's Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age is the main risk factor for the development of neurodegenerative diseases. In the aged brain, axonal degeneration is an early pathological event, preceding neuronal dysfunction, and cognitive disabilities in humans, primates, rodents, and invertebrates. Necroptosis mediates degeneration of injured axons, but whether necroptosis triggers neurodegeneration and cognitive impairment along aging is unknown. Here, we show that the loss of the necroptotic effector Mlkl was sufficient to delay age‐associated axonal degeneration and neuroinflammation, protecting against decreased synaptic transmission and memory decline in aged mice. Moreover, short‐term pharmacologic inhibition of necroptosis targeting RIPK3 in aged mice, reverted structural and functional hippocampal impairment, both at the electrophysiological and behavioral level. Finally, a quantitative proteomic analysis revealed that necroptosis inhibition leads to an overall improvement of the aged hippocampal proteome, including a subclass of molecular biofunctions associated with brain rejuvenation, such as long‐term potentiation and synaptic plasticity. Our results demonstrate that necroptosis contributes to age‐dependent brain degeneration, disturbing hippocampal neuronal connectivity, and cognitive function. Therefore, necroptosis inhibition constitutes a potential geroprotective strategy to treat age‐related disabilities associated with memory impairment and cognitive decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NecroptosisNeurodegenerative DiseasesHumansMiceAnimalsAgedProteomicsRejuvenationAgingBrainMemory Disorders

Stichwörter der Autor:innen

agingaxon pathologycognitionhippocampusmemorynecroptosisrejuvenationsynaptic transmission

Autor:innen und Institutionen

  • Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
  • Geroscience Center for Brain Health and Metabolism (GERO), Santiago, Chile.
  • Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • The Roslin Institute, University of Edinburgh, Edinburgh, UK.
  • Massive Analytic Ltd., London, UK.
  • FingerPrints Proteomics Facility, School of Life Sciences, University of Dundee, Dundee, UK.

ORCID-Profile: Macarena S Arrázola, Matías Lira, Felipe Véliz-Valverde, Gabriel Quiroz, Somya Iqbal, Douglas J Lamont, Hernán Huerta, Gonzalo Ureta, J César Cárdenas, Waldo Cerpa, Thomas M Wishart, Felipe A Court

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Fondo Nacional de Desarrollo Científico y Tecnológico
  • Michael J. Fox Foundation for Parkinson's Research

Zitieren

APA

Arrázola, M. S., Lira, M., Véliz-Valverde, F., Quiroz, G., Iqbal, S., Eaton, S. L., Lamont, D. J., Huerta, H., Ureta, G., Bernales, S., Cárdenas, J. C., Cerpa, W., Wishart, T. M., & Court, F. A. (2023). Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation. Aging Cell, 22(5). https://doi.org/10.1111/acel.13814

Vancouver

Arrázola MS, Lira M, Véliz-Valverde F, Quiroz G, Iqbal S, Eaton SL, et al. Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation. Aging Cell. 2023;22(5). doi:10.1111/acel.13814

BibTeX
@article{Arrzola2023,
  author = {Arrázola, Macarena S and Lira, Matías and Véliz-Valverde, Felipe and Quiroz, Gabriel and Iqbal, Somya and Eaton, Samantha L and Lamont, Douglas J and Huerta, Hernán and Ureta, Gonzalo and Bernales, Sebastián and Cárdenas, J César and Cerpa, Waldo and Wishart, Thomas M and Court, Felipe A},
  title = {Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation},
  journal = {Aging Cell},
  year = {2023},
  volume = {22},
  number = {5},
  doi = {10.1111/acel.13814}
}
Kostenlos starten →